|
Year
end analysis of global sales 1998 <<
Page 2 of 3 >>
Leading Therapy Classes
The top ten therapy classes
accounted for nearly 30 percent of the total world market
in 1998 (SEE TABLE). Three out of the leading ten, Cholesterol
& Triglyceride Reducers, Antidepressants and Antipsychotics,
are growing at 20 percent or more, year-over-year.
The Antiulcerant class, is
valued at $12.9 billion, and remains the leading therapeutic
class world-wide in 1998, as it has for the past eight
years. Losec (omeprazole), the world’s leading antiulcerant
product, accounts for nearly 30 percent of all sales in
this class.
The Cholesterol & Triglyceride
Reducers class, grew at a very strong 20 percent, placing
this class at 2 in the rankings. Antidepressants grew
by an even greater 21 percent, placing this class of drugs
in the 3 position.
Outside of the top ten classes,
by far the fastest growing sub-class is Erectile Dysfunction,
which grew by 277 percent in 1998, driven by the blockbuster
launch of Viagra. This class is worth $0.7 billion, and
is ranked in 79th place. The second fastest
growing class is compounds used to treat heart indications,
the Angiotensin II Antagonists. Currently in 56th
place, Angiotensin II Antagonists grew last year by 104
percent to $1.1 billion. This has been mirrored by a slow
down in growth in older cardiovascular drug classes such
as Calcium Antgaonists -1% and the first generation Ace
Inhibitors 1%. Other therapeutic classes to feel a slowdown
include the traditional H2 Antagonists down 18% and non-narcotic
analgesics declining 5%.
WORLDWIDE
LEADING THERAPEUTIC CLASSES 1998
Audited Sales by 3rd Level Therapeutic Class
|
|
$ Growth
|
Growth at
|
|
|
Constant Exchange
|
|
ATC3
|
ATC Description
|
Mill($)
|
+($)
|
(+LCD)
|
|
A2B
|
ANTIULCERANTS
|
12919
|
1
|
3
|
|
C10A
|
CHOLEST & TRIGLY REDUCER
|
9635
|
17
|
20
|
|
N6A
|
ANTIDEPRESSANTS
|
9393
|
19
|
21
|
|
C8A
|
CALCIUM ANTAGONIST PLAIN
|
8656
|
-1
|
1
|
|
J1D
|
CEPHALOSPORINS & COMBS
|
6878
|
-5
|
-1
|
|
C9A
|
ACE INHIBITORS PLAIN
|
6529
|
1
|
4
|
|
N2B
|
NON-NARCOTIC ANALGESICS
|
6229
|
-7
|
-4
|
|
M1A
|
ANTIRHEUMATIC N-STEROID
|
6020
|
1
|
4
|
|
N5A
|
ANTIPSYCHOTICS
|
3921
|
28
|
30
|
|
J1C
|
BROAD SPECTR.PENICILLINS
|
3818
|
-1
|
4
|
|
|
LEADING 10
|
73998
|
4
|
7
|
|
TOTAL AUDITED MARKET
|
252698
|
4
|
7
|
For
full explanation of figures and collection methods see
Data Value and definitions
|